Search research articles
Contact Us
Filters
Showing results (211-220 of 234) with videos related to
Page
of 24
Sort By:
The American Journal of Medicine
|
October 18, 2024
Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure
Phillip H Lam, Kevin Liu, Amiya A Ahmed, et al.
Health Physics
|
January 26, 2017
Design of Interrogation Protocols for Radiation Dose Measurements Using Optically-Stimulated Luminescent Dosimeters
Sara A Abraham, Kimberlee J Kearfott, Ali H Jawad, et al.
Molecular Cancer Research : MCR
|
September 25, 2020
A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma
Tiantian Cui, Erica H Bell, Joseph McElroy, et al.
American Journal of Hematology
|
January 28, 2022
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial
Evangelos Terpos, Meletios A Dimopoulos, Mario Boccadoro, et al.
Nutrients
|
June 2, 2021
Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial
Xue-Jun Kong, Jun Liu, Kevin Liu, et al.
Endoscopy International Open
|
February 29, 2024
The Bethesda ERCP Skills Assessment Tool (BESAT) can reliably differentiate endoscopists of different experience levels
Kevin Liu, B Joseph Elmunzer, Sachin Wani, et al.
Journal of Neuro-Oncology
|
June 25, 2022
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis
Joshua D Palmer, Haley K Perlow, Jennifer K Matsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial
Maria-Victoria Mateos, Paul G Richardson, Rudolf Schlag, et al.
European Journal of Haematology
|
March 4, 2011
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma
Michel Delforge, Evangelos Terpos, Paul G Richardson, et al.
The New England Journal of Medicine
|
August 30, 2008
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesús F San Miguel, Rudolf Schlag, Nuriet K Khuageva, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 234) with videos related to
Sort By:
Page
of 24
The American Journal of Medicine
|
October 18, 2024
Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure
Phillip H Lam, Kevin Liu, Amiya A Ahmed, et al.
Health Physics
|
January 26, 2017
Design of Interrogation Protocols for Radiation Dose Measurements Using Optically-Stimulated Luminescent Dosimeters
Sara A Abraham, Kimberlee J Kearfott, Ali H Jawad, et al.
Molecular Cancer Research : MCR
|
September 25, 2020
A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma
Tiantian Cui, Erica H Bell, Joseph McElroy, et al.
American Journal of Hematology
|
January 28, 2022
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial
Evangelos Terpos, Meletios A Dimopoulos, Mario Boccadoro, et al.
Nutrients
|
June 2, 2021
Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial
Xue-Jun Kong, Jun Liu, Kevin Liu, et al.
Endoscopy International Open
|
February 29, 2024
The Bethesda ERCP Skills Assessment Tool (BESAT) can reliably differentiate endoscopists of different experience levels
Kevin Liu, B Joseph Elmunzer, Sachin Wani, et al.
Journal of Neuro-Oncology
|
June 25, 2022
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis
Joshua D Palmer, Haley K Perlow, Jennifer K Matsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial
Maria-Victoria Mateos, Paul G Richardson, Rudolf Schlag, et al.
European Journal of Haematology
|
March 4, 2011
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma
Michel Delforge, Evangelos Terpos, Paul G Richardson, et al.
The New England Journal of Medicine
|
August 30, 2008
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesús F San Miguel, Rudolf Schlag, Nuriet K Khuageva, et al.
Page
of 24